Clinical Trial Update: Neutrophil Elastase and Elafin as Prognostic Biomarker for Acute Respiratory Distress Syndrome

View source ↗

Summary

A completed clinical trial examined neutrophil elastase and elafin as prognostic biomarkers for Acute Respiratory Distress Syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Distress Syndrome

Snippet

Sponsor: Peking University Third Hospital | Conditions: Acute Respiratory Distress Syndrome, ARDS | Status: COMPLETED